Showing results (1621-1630 of 1,710) with videos related to

Sort By:
Pageof 171
JAMA Oncology|April 21, 2022
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus StatementEsther N Pijnappel, J Annelie Suurmeijer, Bas Groot Koerkamp, et al.
Optics Express|October 13, 2022
Real-time spatial characterization of micrometer-sized X-ray free-electron laser beams focused by bendable mirrorsGiuseppe Mercurio, Jaromír Chalupský, Ioana-Theodora Nistea, et al.
Journal for Immunotherapy of Cancer|October 10, 2025
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumorsPeter J Madsen, Anna Melissa Schlitter, Carina Flemmig, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
Nature|January 28, 2026
Lasing of a cavity-based X-ray sourcePatrick Rauer, Immo Bahns, Bertram Friedrich, et al.
Molecular Cancer Therapeutics|October 24, 2015
Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic ModelEva Tonsing-Carter, Barbara J Bailey, M Reza Saadatzadeh, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapyJoao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
Journal of Clinical Gastroenterology|January 26, 2018
Long-term Prognosis of Acute-on-Chronic Liver Failure SurvivorsEileen L Yoon, Tae Yeob Kim, Chang Hyeong Lee, et al.
BMC Pediatrics|February 10, 2020
Standardised neonatal parenteral nutrition formulations - Australasian neonatal parenteral nutrition consensus update 2017Srinivas Bolisetty, David Osborn, Tim Schindler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE studyF Lordick, M E Mauer, G Stocker, et al.
Pageof 171